Reading Time: 2 minutesIntroduction Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has been a cornerstone in the management of type 2 diabetes, primarily due to its efficacy in controlling blood glucose levels. However, recent research has unveiled additional benefits of this medication, particularly …
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.